Peter Kuhn, PhD

Recent Publications

Shishido S, Sayeed S, Courcoubetis G, Djaladat H, Miranda G, Pienta K, Nieva J, Hansel D, Desai M, Gill I, Kuhn P, Mason J. Characterization of cellular and acellular analytes from pre-cystectomy liquid biopsies in patients newly diagnosed with primary bladder cancer. Cancers. 2022;14(3), 758.

  Shishido S, Ghoreifi A, Sayeed S, Courcoubetis G, Huang A, Ye B, Mrutyunjaya S, Gill I, Kuhn P, Mason J, Djaladat H. Liquid Biopsy Landscape in Patients with Primary Upper Tract Urothelial Carcinoma. Cancers. 2022; 14(12), 3007.

Ndacayisaba L, Rappard K, Shishido S, Ruiz C, Matsumoto N, Navarez R, Tang G, Lin P, Setayesh S, Naghdloo A, Hsu C, Maney C, Symer D, Bethel K, Kelly K, Merchant A, Orlowski R, Hicks J, Mason J, Manasanch E, Kuhn P. Enrichment-Free Single-Cell Detection and Morphogenomic Profiling of Myeloma Patient Samples to Delineate Circulating Rare Plasma Cell Clones. Current Oncology. 2022; 29, 2954-72.

Kolencik D, Narayan S, Thiele JA, McKinley D, Gerdtsson A, Welter L, Hosek P, Ostasov P, Vycital O, Bruha J, Fiala O, Sorejs O, Liska V, Pitule P, Kuhn P, Shishido S. Circulating tumor cell kinetics and morphology from the liquid biopsy predict disease progression in patients with metastatic colorectal cancer following resection. Cancers. 2022;14(3), 642.

Mason J, Hasnain Z, Miranda G, Gill K, Djaladat H, Desai M, Paul K, Newton P, Gill I, Kuhn P. Prediction of metastatic patterns in bladder cancer: Spatiotemporal progression and development of a novel, web-based platform for clinical utility. European Urology Open Science. 2021; EUROS-D-21-00063R1.

Xu L, Kim M, Polski A, Prabakar R, Shen L, Peng C, Reid M, Chevez-Barrios P, Kim J, Shah R, Jubran R, Kuhn P, Cobrinik D, Biegel J, Gai X, Hicks J, Berry J. Establishing clinical utility of ctDNA analysis for diagnosis, prognosis, and treatment monitoring of retinoblastoma: the aqueous humor liquid biopsy.  Cancers 2021;13(6):1282.

Kolencik D, Shishido SN, Piutle P, Mason J, Hicks J, Kuhn P. Liquid biopsy in colorectal carcinoma: Clinical applications and challenges. Cancers (Basel). 2020;12:E1376.

Xu L, Polski A, Prabakar R, Reid M, Chevez-Barrios P, Jubran R, Kim J, Kuhn P, Cobrinik D, Hicks J, Berry J. Gain of chromosome 6p is a molecular biomarker for prognostication of retinoblastoma ocular survival: the aqueous humor surrogate tumor biopsy. Molecular Cancer Research. 2020.